Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [1]
The Pakistan Standards & Quality Control Authority (PSQCA; Urdu: مختاریہَ پاکستان برائے انضباطِ کیفیات و معیارات) is an autonomous body subordinate to the ministry of science and technology of the Government of Pakistan. Its main objective is to regulate and enforce quality standards in Pakistan ...
The pharmaceutical industry in Pakistan has grown during the past recent decades. At the time of the independence of Pakistan in 1947, there were few production units in the country. Currently Pakistan has more than 800 large volume pharmaceutical formulation units, including those operated by 25 multinationals present in the country.
The Drug Regulatory Authority of Pakistan (DRAP) is a self-governing entity under the Federal Government of Pakistan. It functions under the administrative supervision of the Ministry of National Health Services, Regulations & Coordination .
Pharmaceutical industry in Pakistan; P. 2012 Pakistan fake medicine crisis This page was last edited on 14 December 2011, at 16:03 (UTC). ...
Pharmaceutical industry in Pakistan (1 C, 2 P) ... Pharmacy schools in Pakistan (3 P) This page was last edited on 15 March 2017, at 12:36 (UTC). ...
The Pakistan Pharmacists Association (PPA) is the national professional body of pharmacists and pharmacy students in Pakistan. Founded by Dr. Naim Anwar Muzzafar , its mission is to promote and expand the profession of pharmacy and the role of pharmacists.
The industry's various subdivisions include distinct areas, such as manufacturing biologics, which are all subject to a variety of laws and regulations that govern the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceutical market produced treatments worth a total of $1,228.45 billion in 2020.